Family-based Association Study of Killer Cell Immunoglobulin-Like Receptor Genes with Leukemia

NK cell function is controlled by the cell expression of killer immunoglobulin-like receptors (KIRs) and their ligation with the corresponding HLA ligands. Various malignancies have been associated with certain KIRs surface cell expression and various KIR/HLA ligand combinations. Prior research usin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Varbanova V., Mihaylova S., Naumova E., Cotoc C., Mihaylova A.
Formato: article
Lenguaje:EN
Publicado: Sciendo 2019
Materias:
kir
R
Acceso en línea:https://doaj.org/article/c075bbca10b24d98ace1facb559622d3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c075bbca10b24d98ace1facb559622d3
record_format dspace
spelling oai:doaj.org-article:c075bbca10b24d98ace1facb559622d32021-12-02T19:05:13ZFamily-based Association Study of Killer Cell Immunoglobulin-Like Receptor Genes with Leukemia0324-175010.2478/amb-2019-0023https://doaj.org/article/c075bbca10b24d98ace1facb559622d32019-10-01T00:00:00Zhttps://doi.org/10.2478/amb-2019-0023https://doaj.org/toc/0324-1750NK cell function is controlled by the cell expression of killer immunoglobulin-like receptors (KIRs) and their ligation with the corresponding HLA ligands. Various malignancies have been associated with certain KIRs surface cell expression and various KIR/HLA ligand combinations. Prior research using case/control study design demonstrates the role of KIR and KIR HLA ligands as genetic factor involved in tumor susceptibility. The objective of this study was to investigate the family-based association of KIRs, HLA class I ligands and KIR/ligand combinations with leukemia diagnosis in families having a leukemia diagnosed child. Sixty-seven families that met the index leukemia case criteria (acute lymphoblastic leukemia, ALL, n = 45; acute myeloid leukemia, AML, n = 13; chronic myeloid leukemia, CML, n = 9; first degree healthy relatives n = 159) were examined. Our study consisted of two phases. In Phase1 case-control study, we primarily compared patients to their healthy siblings to asses if a marker or genotype may be associated with leukemia, excluding the impact of the environment. Phase 2 consisted of a secondary family-based association study. KIR genotyping was performed by PCR-SSP method. KIR HLA ligands were defined by direct method using PCR-SSP method and/or indirect base on high resolution typing of HLA-A, -B, -C alleles. Results of phase 1 showed an increase in the frequency of KIR genotype (with a ratio = 0.57; higher frequency for inhibitory KIRs vs. activating KIRs) among leukemia patients compared to healthy siblings. Results of the phase 2 familial study observed an association between HLA-C1+/BBw4+/ABw4+ haplotype (a mediator of inhibitory signals) and leukemia. Also, we concluded that the absence of HLA-ABw4 alleles was related to leukemia development.Varbanova V.Mihaylova S.Naumova E.Cotoc C.Mihaylova A.Sciendoarticlekirhla class i ligandleukemiafamily-based studyMedicineRENActa Medica Bulgarica, Vol 46, Iss 3, Pp 10-17 (2019)
institution DOAJ
collection DOAJ
language EN
topic kir
hla class i ligand
leukemia
family-based study
Medicine
R
spellingShingle kir
hla class i ligand
leukemia
family-based study
Medicine
R
Varbanova V.
Mihaylova S.
Naumova E.
Cotoc C.
Mihaylova A.
Family-based Association Study of Killer Cell Immunoglobulin-Like Receptor Genes with Leukemia
description NK cell function is controlled by the cell expression of killer immunoglobulin-like receptors (KIRs) and their ligation with the corresponding HLA ligands. Various malignancies have been associated with certain KIRs surface cell expression and various KIR/HLA ligand combinations. Prior research using case/control study design demonstrates the role of KIR and KIR HLA ligands as genetic factor involved in tumor susceptibility. The objective of this study was to investigate the family-based association of KIRs, HLA class I ligands and KIR/ligand combinations with leukemia diagnosis in families having a leukemia diagnosed child. Sixty-seven families that met the index leukemia case criteria (acute lymphoblastic leukemia, ALL, n = 45; acute myeloid leukemia, AML, n = 13; chronic myeloid leukemia, CML, n = 9; first degree healthy relatives n = 159) were examined. Our study consisted of two phases. In Phase1 case-control study, we primarily compared patients to their healthy siblings to asses if a marker or genotype may be associated with leukemia, excluding the impact of the environment. Phase 2 consisted of a secondary family-based association study. KIR genotyping was performed by PCR-SSP method. KIR HLA ligands were defined by direct method using PCR-SSP method and/or indirect base on high resolution typing of HLA-A, -B, -C alleles. Results of phase 1 showed an increase in the frequency of KIR genotype (with a ratio = 0.57; higher frequency for inhibitory KIRs vs. activating KIRs) among leukemia patients compared to healthy siblings. Results of the phase 2 familial study observed an association between HLA-C1+/BBw4+/ABw4+ haplotype (a mediator of inhibitory signals) and leukemia. Also, we concluded that the absence of HLA-ABw4 alleles was related to leukemia development.
format article
author Varbanova V.
Mihaylova S.
Naumova E.
Cotoc C.
Mihaylova A.
author_facet Varbanova V.
Mihaylova S.
Naumova E.
Cotoc C.
Mihaylova A.
author_sort Varbanova V.
title Family-based Association Study of Killer Cell Immunoglobulin-Like Receptor Genes with Leukemia
title_short Family-based Association Study of Killer Cell Immunoglobulin-Like Receptor Genes with Leukemia
title_full Family-based Association Study of Killer Cell Immunoglobulin-Like Receptor Genes with Leukemia
title_fullStr Family-based Association Study of Killer Cell Immunoglobulin-Like Receptor Genes with Leukemia
title_full_unstemmed Family-based Association Study of Killer Cell Immunoglobulin-Like Receptor Genes with Leukemia
title_sort family-based association study of killer cell immunoglobulin-like receptor genes with leukemia
publisher Sciendo
publishDate 2019
url https://doaj.org/article/c075bbca10b24d98ace1facb559622d3
work_keys_str_mv AT varbanovav familybasedassociationstudyofkillercellimmunoglobulinlikereceptorgeneswithleukemia
AT mihaylovas familybasedassociationstudyofkillercellimmunoglobulinlikereceptorgeneswithleukemia
AT naumovae familybasedassociationstudyofkillercellimmunoglobulinlikereceptorgeneswithleukemia
AT cotocc familybasedassociationstudyofkillercellimmunoglobulinlikereceptorgeneswithleukemia
AT mihaylovaa familybasedassociationstudyofkillercellimmunoglobulinlikereceptorgeneswithleukemia
_version_ 1718377173740421120